ChartsAndTrends

COHERUS cracking $21 will unleash major bullish potential

Long
NASDAQ:CHRS   Coherus BioSciences, Inc.
COHERUS BIOSCIENCES Inc., CHRS , is a bioscience company that has not yet not benefited from the sector's outperformance despite significantly improving financials and the business becoming profitable. When the stock price cracks the $21 level it will unlock a significant bullish potential.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.